Regulation of Laboratory-Developed Tests
暂无分享,去创建一个
[1] G. Norman,et al. Drugs and Devices: Comparison of European and U.S. Approval Processes , 2016 .
[2] Van Norman Ga. Drugs, Devices, and the FDA: Part 2: An Overview of Approval Processes: FDA Approval of Medical Devices. , 2016 .
[3] C. Goodman,et al. Food and Drug Administration Center for Devices and Radiological Health , 1988 .
[4] Christine L.H. Snozek,et al. FDA-Cleared versus Laboratory-Developed Tests: Why Start from Scratch When Kits Are Available? , 2017, The journal of applied laboratory medicine.
[5] M. Laposata,et al. Reducing Diagnostic Errors Worldwide Through Diagnostic Management Teams , 2018, Annals of laboratory medicine.
[6] Elaine Lyon,et al. The Spectrum of Clinical Utilities in Molecular Pathology Testing Procedures for Inherited Conditions and Cancer: A Report of the Association for Molecular Pathology. , 2016, The Journal of molecular diagnostics : JMD.
[7] Marc Levinson. What Is Manufacturing? Why Does the Definition Matter? , 2017 .
[8] D. Jeffery,et al. US Food and Drug Administration Perspectives on Clinical Mass Spectrometry. , 2016, Clinical chemistry.
[9] W. Grody,et al. The Case for Laboratory Developed Procedures , 2017, Academic pathology.
[10] Annette S. Kim,et al. Comparison of Laboratory-Developed Tests and FDA-Approved Assays for BRAF, EGFR, and KRAS Testing , 2017, JAMA oncology.
[11] Ronald L Weiss,et al. Laboratory-Developed Tests: A Legislative and Regulatory Review. , 2017, Clinical chemistry.
[12] G. Norman,et al. Drugs, Devices, and the FDA: Part 2: An Overview of Approval Processes: FDA Approval of Medical Devices , 2016 .
[13] Richard C. Friedberg,et al. International Organization for Standardization (ISO) 15189 , 2017, Annals of laboratory medicine.
[14] J. Genzen,et al. Reliability and Validity of Proposed Risk Stratification Methods for Laboratory Developed Tests. , 2018, Laboratory medicine.
[15] Van Norman Ga. Drugs and Devices: Comparison of European and U.S. Approval Processes. , 2016 .